Paciente de 82 años con masa pulmonar de 10 meses de evolución, reporte de caso clínico
Palabras clave:
Linfoma no Hodgkin primario de pulmón, patología, biopsia
Resumen
Se presenta una paciente de 82 años, sin sintomatología respiratoria, inicia con dolor inespecífico en hipocondrio izquierdo, sector en el que tras 10 mes aparece una masa. De la cual se toma una biopsia que no es concluyente, pero en exámenes de imagen se observa varios nódulos pulmonares y una masa de la cual se toma una biopsia y se obtiene el diagnóstico.
Descargas
La descarga de datos todavía no está disponible.
Citas
1. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J. 2002;20(3):750–62.
2. Poletti V, Zinzani P, Tomassetti S, Chilosi M. Lymphoproliferative lung disorders. Prog Respir Res. 2007;36:307–22.
3. Zinzani PL, Martelli M, Poletti V, Vitolo U, Gobbi PG, Chisesi T, et al. Practice guidelines for the management of extranodal non-Hodgkin’s lymphomas of adult non-immunodeficient patients. Part I: Primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematol. Haematologica. 2008;93(9):1364–71.
4. NCCN. B-Cell Lymphomas. Natl Compr Cancer Netw [Internet]. 2021;Version 3. Available from: https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf
5. Kim JH, Lee SH, Park J, Kim HY, Lee S Il, Park JO, et al. Primary pulmonary non-Hodgkin’s lymphoma. Jpn J Clin Oncol. 2004;34(9):510–4.
6. Pasquale F. Primary non-Hodgkin’s lymphoma of the lung. Acta Oncol (Madr). 1999;38(5):655–8.
7. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol. 2014;89(3):310–4.
8. Hare SS, Souza CA, Bain G, Seely JM, Gomes MM, Quigley M. The radiological spectrum of pulmonary lymphoproliferative disease. Br J Radiol. 2012;85(1015):848–64.
9. Jiang AG, Gao XY, Lu HY. Diagnosis and management of a patient with primary pulmonary diffuse large B-cell lymphoma: A case report and review of the literature. Exp Ther Med. 2014;8(3):797–800.
10. Salles G, De Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, et al. Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: A study from the Lunenburg Lymphoma Biomarker Consortium. Blood. 2011;117(26):7070–8.
11. Neri N, Nambo MJ, Avilés A. Diffuse large B-cell lymphoma primary of lung. Hematology. 2011;16(2):110–2.
12. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of imaging in the staging and response assessment of lymphoma: Consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32(27):3048–58.
13. Johnson SA, Kumar A, Matasar MJ, Schöder H, Rademaker J. Imaging for staging and response assessment in lymphoma. Radiology. 2015;276(2):323–38.
14. Olszewski AJ, Winer ES, Castillo JJ. Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base. Cancer Causes Control. 2015;26(8):1163–72.
15. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: The lugano classification. J Clin Oncol. 2014;32(27):3059–67.
2. Poletti V, Zinzani P, Tomassetti S, Chilosi M. Lymphoproliferative lung disorders. Prog Respir Res. 2007;36:307–22.
3. Zinzani PL, Martelli M, Poletti V, Vitolo U, Gobbi PG, Chisesi T, et al. Practice guidelines for the management of extranodal non-Hodgkin’s lymphomas of adult non-immunodeficient patients. Part I: Primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematol. Haematologica. 2008;93(9):1364–71.
4. NCCN. B-Cell Lymphomas. Natl Compr Cancer Netw [Internet]. 2021;Version 3. Available from: https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf
5. Kim JH, Lee SH, Park J, Kim HY, Lee S Il, Park JO, et al. Primary pulmonary non-Hodgkin’s lymphoma. Jpn J Clin Oncol. 2004;34(9):510–4.
6. Pasquale F. Primary non-Hodgkin’s lymphoma of the lung. Acta Oncol (Madr). 1999;38(5):655–8.
7. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol. 2014;89(3):310–4.
8. Hare SS, Souza CA, Bain G, Seely JM, Gomes MM, Quigley M. The radiological spectrum of pulmonary lymphoproliferative disease. Br J Radiol. 2012;85(1015):848–64.
9. Jiang AG, Gao XY, Lu HY. Diagnosis and management of a patient with primary pulmonary diffuse large B-cell lymphoma: A case report and review of the literature. Exp Ther Med. 2014;8(3):797–800.
10. Salles G, De Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, et al. Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: A study from the Lunenburg Lymphoma Biomarker Consortium. Blood. 2011;117(26):7070–8.
11. Neri N, Nambo MJ, Avilés A. Diffuse large B-cell lymphoma primary of lung. Hematology. 2011;16(2):110–2.
12. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of imaging in the staging and response assessment of lymphoma: Consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32(27):3048–58.
13. Johnson SA, Kumar A, Matasar MJ, Schöder H, Rademaker J. Imaging for staging and response assessment in lymphoma. Radiology. 2015;276(2):323–38.
14. Olszewski AJ, Winer ES, Castillo JJ. Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base. Cancer Causes Control. 2015;26(8):1163–72.
15. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: The lugano classification. J Clin Oncol. 2014;32(27):3059–67.
Publicado
2022-03-28
Cómo citar
1.
Fernández Freire M, Fernández A, Pantoja S, Sangoquiza S, Tixi R. Paciente de 82 años con masa pulmonar de 10 meses de evolución, reporte de caso clínico. PFR [Internet]. 28 de marzo de 2022 [citado 21 de noviembre de 2024];7(1). Disponible en: https://practicafamiliarrural.org/index.php/pfr/article/view/198
Sección
Casos clínicos y Ejercicios clínico patológicos
Derechos de autor 2022 Práctica Familiar Rural
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
